Company page

Precigen, Inc.

Precigen, Inc. is a public company traded under the ticker PGEN in the American market. With a market capitalization of approximately $1.93 billion, Precigen focuses on advancing innovative gene and cell therapies. The company's mission is to transform the treatment of diseases through its proprietary technologies and research initiatives.